These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 19734603)

  • 1. Antimicrobial resistance in outpatient Escherichia coli urinary isolates in Dakar, Senegal.
    Sire JM; Nabeth P; Perrier-Gros-Claude JD; Bahsoun I; Siby T; Macondo EA; Gaye-Diallo A; Guyomard S; Seck A; Breurec S; Garin B
    J Infect Dev Ctries; 2007 Dec; 1(3):263-8. PubMed ID: 19734603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited.
    Kahlmeter G; Poulsen HO
    Int J Antimicrob Agents; 2012 Jan; 39(1):45-51. PubMed ID: 22055529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition.
    Smith SP; Manges AR; Riley LW
    Clin Infect Dis; 2008 Mar; 46(5):689-95. PubMed ID: 18230040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of Escherichia coli strains isolated from outpatient children with community-acquired urinary tract infection in southern Switzerland.
    Borsari AG; Bucher B; Brazzola P; Simonetti GD; Dolina M; Bianchetti MG
    Clin Ther; 2008 Nov; 30(11):2090-5. PubMed ID: 19108796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain.
    Gobernado M; Valdés L; Alós JI; García-Rey C; Dal-Ré R; García-de-Lomas J;
    Rev Esp Quimioter; 2007 Mar; 20(1):68-76. PubMed ID: 17530038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing antimicrobial resistance in Escherichia coli isolates from community-acquired urinary tract infections during 1998-2003 in Manisa, Turkey.
    Kurutepe S; Surucuoglu S; Sezgin C; Gazi H; Gulay M; Ozbakkaloglu B
    Jpn J Infect Dis; 2005 Jun; 58(3):159-61. PubMed ID: 15973007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and antimicrobial susceptibility of Escherichia coli in outpatient urinary isolates in Izmir, Turkey.
    Yilmaz N; Agus N; Yurtsever SG; Pullukcu H; Gulay Z; Coskuner A; Kose S; Aydemir S; Gulenc N; Ozgenc O
    Med Sci Monit; 2009 Nov; 15(11):PI61-5. PubMed ID: 19865064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Rodríguez-Baño J; Alcalá JC; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
    Arch Intern Med; 2008 Sep; 168(17):1897-902. PubMed ID: 18809817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection.
    Kahlmeter G; Menday P; Cars O
    J Antimicrob Chemother; 2003 Dec; 52(6):1005-10. PubMed ID: 14613955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections.
    Azap OK; Arslan H; Serefhanoğlu K; Colakoğlu S; Erdoğan H; Timurkaynak F; Senger SS
    Clin Microbiol Infect; 2010 Feb; 16(2):147-51. PubMed ID: 19689464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinolone resistance in female outpatient urinary tract isolates of Escherichia coli: age-related differences.
    Gobernado M; Valdés L; Alós JI; Garcia-Rey C; Dal-Ré R; García-de-Lomas J;
    Rev Esp Quimioter; 2007 Jun; 20(2):206-10. PubMed ID: 17893757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [E. coli: resistance to quinolones and beta-lactams of clinical strains isolated in the Franche-Comté region of France].
    Talon D; Lallemand-De-Conto S; Thouverez M; Bertrand X
    Pathol Biol (Paris); 2004 Mar; 52(2):76-81. PubMed ID: 15001235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for antibiotic-resistant Escherichia coli isolated from community-acquired urinary tract infections in Dakar, Senegal.
    Dromigny JA; Nabeth P; Juergens-Behr A; Perrier-Gros-Claude JD
    J Antimicrob Chemother; 2005 Jul; 56(1):236-9. PubMed ID: 15890716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial resistance of urinary tract pathogens in children in Crete, Greece.
    Anatoliotaki M; Galanakis E; Schinaki A; Stefanaki S; Mavrokosta M; Tsilimigaki A
    Scand J Infect Dis; 2007; 39(8):671-5. PubMed ID: 17654342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams.
    Kariuki S; Revathi G; Corkill J; Kiiru J; Mwituria J; Mirza N; Hart CA
    J Infect Dev Ctries; 2007 Dec; 1(3):257-62. PubMed ID: 19734602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro activity of fosfomycin trometamol in the treatment of Escherichia coli related uncomplicated urinary tract infections].
    Hoşbul T; Ozyurt M; Baylan O; Bektöre B; Ardiç N; Ceylan S; Erdemoğlu A; Haznedaroğlu T
    Mikrobiyol Bul; 2009 Oct; 43(4):645-9. PubMed ID: 20084918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data.
    Alós JI; Serrano MG; Gómez-Garcés JL; Perianes J
    Clin Microbiol Infect; 2005 Mar; 11(3):199-203. PubMed ID: 15715717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility of pathogens isolated from adult patients with uncomplicated community-acquired urinary tract infections in the Russian Federation: two multicentre studies, UTIAP-1 and UTIAP-2.
    Stratchounski LS; Rafalski VV
    Int J Antimicrob Agents; 2006 Aug; 28 Suppl 1():S4-9. PubMed ID: 16829055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antimicrobial resistance profiles of community-acquired uropathogenic Escherichia coli isolates during 2004-2006 in a training hospital in Istanbul].
    Ozyurt M; Haznedaroğlu T; Sahiner F; Oncül O; Ceylan S; Ardiç N; Erdemoğlu A
    Mikrobiyol Bul; 2008 Apr; 42(2):231-43. PubMed ID: 18697421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.